@xconomy.com 4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com 4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com 4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com 4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@techcrunch.com 4 years ago
Only 2% of genomic material available for research comes from Africa, 54gene wants to change that
@techcrunch.com 4 years ago
Using full-body MRIs, Ezra can now detect 11 cancers in men and 13 in women
@xconomy.com 5 years ago
CPRIT Grants, TMC & Baird, Shipt & Drive.ai Expand, & More TX Tech